EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Amyloids and the Heart: An Update

Filippos Triposkiadis iD, Alexandros Briasoulis iD, Andrew Xanthopoulos iD

Journal of Clinical Medicine · 27.11.2024 · 13 (23) · 7210

DOI: 10.3390/jcm13237210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.11.2024. Verfasst von Filippos Triposkiadis und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloids consist of fibrils that can be formed by a large variety of different precursor proteins. In localized amyloidosis, amyloids accumulate at the production site with a single organ being affected, whereas in systemic amyloidosis several organs are affected, with the heart being the most common, followed by the kidneys, liver, and the nervous system. The two most frequent systemic amyloidosis types affecting the heart in the vast majority (>95%) of cases are immunoglobulin light chain (AL) amyloidosis and transthyretin (TTR) amyloidosis (ATTR amyloidosis). Patients with amyloid cardiopathy (CA) often present with non-specific heart failure symptoms as well as other clinical manifestations depending on the organ or systems involved. However, there are some findings associated with amyloidosis called “red flags” (clinical, echocardiographic, magnetic resonance imaging), which may assist in guiding the physician to the correct diagnosis. The present state-of-the-art review summarizes the features of the various cardiac phenotypic expressions of amyloidosis, proposes a simplified pathway for its diagnosis, and highlights the rapidly evolving therapeutic landscape.

Schlagwörter

Stichwörter der Autor:innen

cardiac amyloidosiscomorbiditieshereditarylight chaintransthyretintreatmentwild type

Autor:innen und Institutionen

  • School of Medicine, European University Cyprus, 2404 Nicosia, Cyprus.
  • Department of Clinical Therapeutics, Faculty of Medicine, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.

ORCID-Profile: Filippos Triposkiadis, Alexandros Briasoulis, Andrew Xanthopoulos

Zitieren

APA

Triposkiadis, F., Briasoulis, A., & Xanthopoulos, A. (2024). Amyloids and the Heart: An Update. Journal of Clinical Medicine, 13(23), 7210. https://doi.org/10.3390/jcm13237210

Vancouver

Triposkiadis F, Briasoulis A, Xanthopoulos A. Amyloids and the Heart: An Update. Journal of Clinical Medicine. 2024;13(23):7210. doi:10.3390/jcm13237210

BibTeX
@article{Triposkiadis2024,
  author = {Triposkiadis, Filippos and Briasoulis, Alexandros and Xanthopoulos, Andrew},
  title = {Amyloids and the Heart: An Update},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {23},
  pages = {7210},
  doi = {10.3390/jcm13237210}
}
Kostenlos starten →